Fennec Pharmaceuticals (FENC) Total Liabilities (2010 - 2025)

Fennec Pharmaceuticals' Total Liabilities history runs 16 years deep, the most recent figure standing at $35.1 million for Q4 2025.

• Quarterly Total Liabilities fell 30.97% year-over-year to $35.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.1 million (down 30.97% YoY) and the FY2025 annual result came in at $35.1 million, down 30.97% from the prior year.
• Total Liabilities was $35.1 million for Q4 2025 at Fennec Pharmaceuticals, down from $53.8 million in the prior quarter.
• Across five years, Total Liabilities topped out at $66.2 million in Q1 2024 and bottomed at $5.8 million in Q2 2021.
• A 5-year average of $34.2 million and a median of $29.5 million in 2022 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2021 — Total Liabilities plunged 85.16% — and 2022, when it jumped 344.26%.
• Fennec Pharmaceuticals' Total Liabilities stood at $6.6 million in 2021, then jumped by 344.26% to $29.5 million in 2022, then jumped by 30.43% to $38.5 million in 2023, then soared by 32.04% to $50.8 million in 2024, then sank by 30.97% to $35.1 million in 2025.
• Business Quant data shows FENC's Total Liabilities at $35.1 million in Q4 2025, $53.8 million in Q3 2025, and $52.3 million in Q2 2025.